ACC House Call: The Decision to Go Virtual

Article

An ACC board member explains the major cardiology college's decision to move the meeting online during the COVID-19 pandemic.

The decision to convert the American College of Cardiology (ACC) 2020 Scientific Sessions from in-person to completely virtual wasn’t a simple one.

For the sake of public health during the novel coronavirus (COVID-19) spread, yes, it may have been an easy call. But with consideration to the extent of work and compliance needed to pull it off in time for the meeting’s start date on March 28, it was an unprecedented task.

In a special edition House Call interview with HCPLive®, B. Hadley Wilson, MD, Executive Vice Chair of Atrium Health Sanger Heart and Vascular Institute, and ACC Board of Trustees member and Chair of the Membership Committee, explained what went behind the college’s decision, how they plan to gauge the virtual meeting’s successes, and what these circumstance could mean for future virtual offerings.

“As with challenges, there are potential opportunities,” Wilson said. “And we looked at this as, ‘Let not just cancel the meeting entirely. Let’s look at ways to get this extremely important cardiovascular information out there.’”

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.